APA (7th ed.) Citation

Ou, S., Wang, B., Luo, J., & Jiang, Q. Beyond efficacy parity: A novel cost-equilibrium framework for value assessment of competing third-line therapies in metastatic colorectal cancer. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Ou, Shunlong, Bingjie Wang, Jing Luo, and Qian Jiang. Beyond Efficacy Parity: A Novel Cost-equilibrium Framework for Value Assessment of Competing Third-line Therapies in Metastatic Colorectal Cancer. Frontiers Media S.A.

MLA (9th ed.) Citation

Ou, Shunlong, et al. Beyond Efficacy Parity: A Novel Cost-equilibrium Framework for Value Assessment of Competing Third-line Therapies in Metastatic Colorectal Cancer. Frontiers Media S.A.